FGF1 and colorectal carcinoma: Interestingly, inhibiting AKR1B10 restored FGF1 expression levels following the latter’s knockdown (Figure 5B) but its overexpression did not rescue the CRC cells from the anti-proliferative effects of FGF1 knockdown (Figure 5C–5E).